Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000696884 | SCV000825464 | uncertain significance | MHC class II deficiency | 2022-02-25 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 482 of the CIITA protein (p.Glu482Lys). This variant is present in population databases (rs772224355, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with CIITA-related conditions. ClinVar contains an entry for this variant (Variation ID: 574840). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Center for Genomic Medicine, |
RCV003493706 | SCV004242673 | uncertain significance | not specified | 2024-02-06 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000696884 | SCV001462174 | uncertain significance | MHC class II deficiency | 2020-04-24 | no assertion criteria provided | clinical testing |